All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
TEGOYES 15MG CAPSULE_1
TEGOYES 15MG CAPSULE_2
TEGOYES 15MG CAPSULE_3
TEGOYES 15MG CAPSULE_1
23% Off

Tegoyes 15mg Capsule

Prescription Required

Salt Composition : Tegafur,gimeracil,oteracil

Manufacturer : TORRENT PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: ₹2967
Price : ₹2290
You Save : ₹677 (23%)

7 Capsule(s) In A Strip

Pincode
Delivery By -

Patient Assistance Programs
Know About PAP

Get financial assistance directly from pharma companies and cover your cost of medicines or get free medicines for the eligible patient with patient assistance programs (PAP). We provide proper guidance assistance to patients getting enrolled in the patient assistance program.

Introduction to Tegoyes 15mg Capsule

Tegoyes 15mg Capsule is a combination chemotherapy medication containing the active constituents Tegafur, Gimeracil, Oteracil. The combination chemotherapy treatment known as S-1 is used to treat various types of cancer, including gastric, colorectal, breast, and pancreatic cancer. This capsule is not recommended for adolescents and children under 18 and may be given alone or in combination with other anticancer drugs. 

It is important to inform your health care provider if you have severe blood disorders, kidney disorders, viral infections, or you know you have DPD (enzyme dihydropyrimidine dehydrogenase) deficiency. Tegoyes 15mg Capsule contains lactose. So, if you have an intolerance to sugars, you need to inform the physician. Use effective contraceptive measures during the therapy and for at least 6 after the last dose.


Uses of Tegoyes 15mg Capsule

Tegoyes 15mg Capsule is used in the treatment of

  • Gastric cancer
  • Colorectal cancer
  • Breast cancer
  • Pancreatic cancer

Therapeutic Effects of Tegoyes 15mg Capsule

Tegoyes 15mg Capsule inhibits the growth and division of cancer cells, improves the effectiveness of the treatment, and reduces the risk of side effects, thereby providing therapeutic benefits to cancer patients.


Interaction of Tegoyes 15mg Capsule with other drugs

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Tegoyes 15mg Capsule, reducing effectiveness by causing undesirable side effects.


More Information about Tegoyes 15mg Capsule

  • Store in a refrigerator between 20°C to 25°C (68°F to 77°F).
  • Keep away from moisture, heat, and light.
  • It should not be frozen.
  • Keep it in its original packaging until it is ready to be used.
  • Keep out of the reach of children and pets.

How to consume Tegoyes 15mg Capsule

Tegoyes 15mg Capsules are typically taken orally, with or without food. The Capsule should be swallowed whole, not crushed, chewed, or broken. The recommended dosage can vary depending on the type of cancer being treated and other factors such as your overall health and response to treatment. Do not take a double dose to make up for a missed dose.


Safety Advices for Tegoyes 15mg Capsule

Image Not Available  

Pregnancy

  

Tegoyes 15mg Capsule is unsafe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this medicine.

Image Not Available  

Breast Feeding

  

It is unknown whether Tegoyes 15mg Capsules are excreted into human breast milk, so breastfeeding women should consult a doctor before taking it.

Image Not Available  

Lungs

  

If you have a lung disease or lung cancer and are considering treatment with Tegoyes 15mg Capsule, it is important to discuss this medication's potential benefits and risks with your healthcare provider.

Image Not Available  

Liver

  

Tegoyes 15mg Capsule is metabolized in the liver, and their use may be associated with potential liver toxicity. Patients with preexisting liver disease or impairment may be at an increased risk for adverse effects when taking these medications.

Image Not Available  

Alcohol

  

Patients taking Tegoyes 15mg Capsules avoid or limit their alcohol consumption, as alcohol can exacerbate certain side effects of the medication, such as fatigue and depression.

Image Not Available  

Driving

  

Patients should always monitor their response to the Tegoyes 15mg Capsule medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.


Side Effects of Tegoyes 15mg Capsule

Like all medications, Tegoyes 15mg Capsules cause some side effects, although not everyone will experience them. 

Serious:

  • Infection (fever, chills, sore throat, cough, flu-like symptoms)
  • Bleeding or bruising (nosebleeds, bleeding gums)
  • Shortness of breath or difficulty breathing
  • Chest pain
  • Irregular heartbeat
  • Seizures
  • Allergic reaction (swelling of the face, tongue, or throat; difficulty breathing)
  • Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain)
  • Kidney problems (changes in urine output, swelling of the hands or feet)

Common:

  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Fatigue
  • Mouth sores
  • Skin rash
  • Changes in taste
  • Abdominal pain
  • Constipation
  • Headache

Word of Advice

If you have been prescribed Tegoyes 15mg Capsule, it is important to carefully read and understand the warnings and precautions associated with the medication. It increases the risk of infection, so patients should avoid close contact with infected persons. If you have an intolerance to sugars, you need to inform the physician. Avoid consumption of grapefruit during treatment. Use effective contraceptive measures during the therapy and for at least 6 after the last dose. Patients with diabetes require close monitoring during treatment. Always maintain a healthy and balanced diet to support your overall health and well-being.


FAQs

Q 1. Can Tegoyes 15mg Capsule be used in children?

Tegoyes 15mg Capsule is generally not recommended for use in children. There is limited information on the safety and effectiveness of these medications in pediatric patients, and other treatments may be more appropriate.

Q 2. Can Tegoyes 15mg Capsule be used in elderly patients?

Elderly patients may be more susceptible to the side effects of Tegoyes 15mg Capsule, particularly bone marrow suppression and liver toxicity. Your healthcare provider may adjust the dosage or monitor you more closely during the treatment.

Q 3. Can Tegoyes 15mg Capsule be used in patients with kidney disease?

Tegoyes 15mg Capsule are primarily eliminated from the body through the liver so they may be appropriate for use in patients with mild to moderate kidney disease. However, patients with severe kidney disease may require dose adjustments or close monitoring.

Q 4. Can Tegoyes 15mg Capsule affect my mental health?

Tegoyes 15mg Capsules are not commonly associated with effects on mental health. However, like many cancer treatments, they can cause fatigue, contributing to feelings of low mood or depression.

Q 5. How will Tegoyes 15mg Capsule affect my blood?

Tegoyes 15mg Capsule can affect your blood cell counts, particularly your white blood cell count, which can increase your risk of infections. It can also cause anemia (low red blood cell count) and thrombocytopenia (low platelet count). These effects are usually temporary and reversible when treatment is stopped.

Q 6. How will Tegoyes 15mg Capsule affect my heart?

Tegoyes 15mg Capsule may affect your heart in certain ways. While not a common side effect, these medications have been associated with cardiac events such as irregular heartbeat (arrhythmia) and heart attack.


Fact Box of Tegoyes 15mg Capsule

Molecule name: Tegafur, Gimeracil, and Oteracil

Therapeutic class: Anticancer 

Pharmacological class: Antineoplastic agent

Indications: 

1. Gastric cancer

2. Colorectal cancer

3. Breast cancer

4. Pancreatic cancer


References

  1. Nordic Group BV, European Medicines Agency, [Revised on 19/11/2020], [Accessed on 06/05/2023],https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf
  2. Masao Kobayakawa, Yasushi Kojima; Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies; OncoTargets and Therapy; [Published on 2011]; [Accessed on 06/05/2023]; https://pubmed.ncbi.nlm.nih.gov/22162925/
  3. Mahlberg R et al; New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin; Chemotherapy; [Published on 2017]; [Accessed on 06/05/2023]; https://www.karger.com/Article/Abstract/443984

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.